Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
22.80
+0.09 (0.40%)
At close: Jul 17, 2026, 4:00 PM EDT
22.00
-0.80 (-3.51%)
Pre-market: Jul 20, 2026, 4:28 AM EDT
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $39. The average 1-year stock price forecast is 71.05% higher than the current stock price, while the lowest is $29 (+27.19%) and the highest is $57 (+150.00%).
Price Target: $39 (+71.05%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 15, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $31 | Buy | Maintains | $31 | +35.96% | Jul 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 | Buy | Maintains | $29 | +27.19% | Jul 15, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $34 | Buy | Maintains | $34 | +49.12% | Jul 15, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $46 | Buy | Maintains | $46 | +101.75% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
344.35M
from 172.35M
Increased by 99.79%
Revenue Next Year
501.86M
from 344.35M
Increased by 45.74%
EPS This Year
-1.68
from -3.29
EPS Next Year
-0.51
from -1.68
EPS and Forward PE are based on non-GAAP adjusted numbers.